Investegate |PureTech Health PLC Announcements | PureTech Health PLC: Vedanta Receives $25M Investment from Pfizer Inc
PureTech Founded Entity Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc. Michael Vincent, M.D., Ph.D., Chief Scientific Officer, Inflammation & Immunology Research Unit at Pfizer, to join Vedantas Scientific Advisory Board PureTech Health plc (LSE: PRTC, NASDAQ: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiate...
Source: investegate.co.uk